Track record · closed signal

Merck & Company Inc (MRK) — closed signal from April 17, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on July 16, 2026.

Predicted vs. what happened

MRK price · publication thesis → realized outcomesplit-adjusted
$116.08 Published $127.92 Target $127.63 Window close $130.29 Peak
$112.38 – $116.32Entry zone — fair-value band
$116.08Published — price the day we called it
$127.92Target — the price the thesis aimed for
$130.29Peak — highest point inside the window, not a realized return
$127.63Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 73 days.

Peak price
$130.29
peak on June 30, 2026 — not a realized return
Peak gain
+12.2%
peak, from the publication price
Window close
$127.63
end-of-window price, context only
Days to target
73
Window
April 17, 2026 – July 16, 2026

The thesis — published April 17, 2026

Predicted growth
+11%
over the measurement window
Target price
$127.92
the price the thesis aimed for
Entry zone
$112.38 – $116.32
the fair-value band we waited for
Price at publication
$116.08
published April 17, 2026
Confidence
75%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Merck looks like a steadier healthcare pick because its near-term story depends on real drug news, not market hype. EU approval for clesrovimab and a priority review for ifinatamab boost visibility for upcoming products. Shares appear sold-off, and solid profits and valuation give some protection. If sentiment improves, a 0-3 month rebound is plausible.

Primary drivers

  • New approval and priority review increase near-term product visibility
  • Good valuation and profitability reduce downside risk
  • Adds healthcare balance to a tech-heavy mix
  • Recent selling leaves room to recover if price steadies

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.